Managing an implantable drug delivery system.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to V Speechley.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In a study to determine whether hospital staff who handle cytotoxic drugs show signs of drug absorption, urinary mutagenicity assays gave positive results in a high proportion of non-exposed control subjects as well as in "exposed" hospital staff and were therefore considered unsuitable for routine monitoring. Determination of urinary platinum levels with atomic-absorption spectrophotometry of untreated urine may be a useful alternative. With this method platinum levels were below the reliable limits of detection in nurses and pharmacists who handled cytotoxic drugs (including platinum-containing drugs) and in controls. The urine of cisplatin-treated patients contained an average platinum level of 7 micrograms/ml, suggesting that contact with urine from patients undergoing intensive chemotherapy may be hazardous.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.